Over the past decade, immunotherapy has fundamentally reshaped the therapeutic landscape for several urological cancers, this mostly involved urothelial ...

Adjuvant pembrolizumab improved recurrence-free survival among patients with resected Merkel cell carcinoma, but not significantly.

The abstracts selected for the press briefing represent an array of the top advances in cancer immunotherapy research. Data shared during the press briefing may be embargoed to a later date and time ...

A 26-year-old man’s suspected UTI turned out to be terminal prostate cancer. Chandler Heatley, went to A&E when he noticed ...